Trial Profile
A Phase I Open-label Trial to Investigate the Pharmacokinetic Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Sep 2015
Price :
$35
*
At a glance
- Drugs Bedaquiline (Primary) ; Rifampicin; Rifapentine
- Indications Tuberculosis
- Focus Pharmacokinetics
- 21 Aug 2014 New trial record